Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.
Chen
H Y
HY
Maskell
J P
JP
Powell
M
M
D000818:Animals; D016470:Bacteremia / Q000382:microbiology / Q000517:prevention & control*; D017291:Clarithromycin / Q000031:analogs & derivatives; D004195:Disease Models, Animal; D004357:Drug Synergism; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy*; D006193:Haemophilus influenzae / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C
C056228:14-hydroxyclarithromycin; D004917:Erythromycin; D017291:Clarithromycin